梅花生物：累计回购3570.84万股

Group 1 - The company Meihua Biological (SH 600873) announced a share buyback of 35.7084 million shares, representing 1.25% of its total share capital of approximately 2.853 billion shares, with a total expenditure of about 352 million RMB [1][1][1] - The share buyback was conducted through centralized bidding, with the lowest purchase price at 9.1 RMB per share and the highest at 10.68 RMB per share, complying with legal regulations and the company's buyback plan [1][1][1] - As of the report date, the market capitalization of Meihua Biological is 31.3 billion RMB [1][1][1] Group 2 - For the fiscal year 2024, the revenue composition of Meihua Biological is as follows: 97.34% from bio-fermentation, 1.9% from pharmaceutical health, and 0.76% from other businesses [1][1][1]